NASDAQ:EQ

Equillium Stock Predictions

Healthcare > Biotechnology

Buy EQ

*Your capital is at risk

$3.11

+0.320 (+11.47%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

EQ Prediction Chart

EQ Predictions History

Latest community submissions for EQ.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	Jun 5, 2023	$0.644 +2.21%	$0.635	V	98.59%	2
robpam4ever.374229	Jun 5, 2023	Bullish	$0.635	V	—	1
JS Pro	Dec 21, 2022	$1.03 +6.19%	$1.01	V	98.02%	1
AlexVel Pro	Dec 21, 2022	$0.89 -8.25%	$1.01	X	88.12%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for EQ with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT EQUILLIUM INC.

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by